Ariad Pharmaceuticals Inc fka ARIA

[wrkingcapital]

How great is it to be invested in a company which might help save lives...The following is another message from the patient board...

Hi everyone,

I have some exciting news.

This morning Ariad announced the start of the Phase II Pivotal Trial of their Pan-BCR/ABL inhibitor, AP24534 (Ponatinib). This is the drug I am presently taking in a Phase I trial. It kills all known mutations of the Philadelphia Chromosome including the T315I. It is the only TKI that inhibits every known point mutation. Dr. Talpaz, who has pioneered virtually every CML treatment in use today, says that, "AP24534 is the best drug ever developed for CML".

This Phase II trial is aimed at getting FDA approval for Ponatinib (AP24534). Below, is the press release from this morning followed by a list of US trial centers. I am trying to get a list of World wide trial centers and I will post them ASAP.

Regards,
Jerry